Buteyko Method for Asthmatic Children With Mouth Breathing (NCT02724657) | Clinical Trial Compass
CompletedNot Applicable
Buteyko Method for Asthmatic Children With Mouth Breathing
Brazil35 participantsStarted 2016-03
Plain-language summary
To assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of asthmatic children with mouth breathing.
Who can participate
Age range7 Years – 12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children from 7 up to 12 years old with asthma diagnose
* Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks.
* Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, and tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.
Exclusion Criteria:
* Children that are not able to perform some of the necessary procedures, give up participating in the research and present acute symptoms of respiratory tract during the assessments.
What they're measuring
1
Change in Sleep disturbance (questionnaire)
Timeframe: Baseline, three weeks later and six months after treatment
Trial details
NCT IDNCT02724657
SponsorUniversidade Federal do Rio Grande do Norte